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LIVER FIBROSIS IS a common result of many chronic liver diseases and if progressive leads to cirrhosis. Cirrhosis has potential complications that include liver failure, portal hypertension, varices, hepatocellular carcinoma (HCC), and hepatic encephalopathy. There is increasing evidence that fibrosis of liver is reversible at early stages and, therefore, early detection of liver fibrosis may be helpful in the management of chronic liver diseases (1) (2) (3) (4) . The treatment of patients with hepatic fibrosis often targets the underlying disease process leading to fibrosis. Knowledge of the extent of liver fibrosis is critical for assessing prognosis and determining clinical management in chronic liver disease due to viral hepatitis. Active antiviral therapy is strongly recommended in chronic hepatitis B patients with cirrhosis; therefore, it may be meaningful to clinicians to detect early cirrhosis for determining timing of antiviral therapy (5, 6) . In chronic hepatitis C, treatment is often advocated for those with at least moderate stage of fibrosis but may not be indicated in those who have minimal or absent fibrosis (7, 8) . Moreover, practice guidelines for treatment of chronic hepatitis C infection with recently approved protease inhibitor drugs require an assessment of fibrosis staging to determine the recommended duration of therapy with these effective but very expensive drugs (9, 10) . Patients with fibrosis that has progressed to cirrhosis are recommended to undergo screening for hepatocellular carcinoma and varices (11) . The conventional standard for the diagnosing and staging liver fibrosis is percutaneous biopsy, which is invasive, expensive, has poor patient acceptance, is prone to interobserver variability and sampling errors, has poor repeatability, and carries a risk of complications estimated at 3% with a mortality rate of 0.03% (12) (13) (14) (15) . Many physicians are reluctant to recommend liver biopsy in asymptomatic patients with progressive hepatic fibrosis due to these concerns. Therefore, tests for noninvasive evaluation of liver fibrosis have been explored, including serum markers, transient elastography (Fibroscan) and MRI based functional imaging methods. Serum markers, although attractive as noninvasive, have variable accuracies for the diagnosis of liver fibrosis (16) . Transient elastography (Fibroscan, Echosens) is an ultrasound based technique for measuring liver stiffness, and it has been shown that there is a strong correlation between this parameter and Figure 1 . MRE is performed in three steps. a: A source of vibration is placed on the surface of the body to generate mechanical waves in the tissues of interest. b: A special MRE pulse sequence with synchronized motion encoding gradients is used to image the micron-level cyclic displacements caused by the propagating waves. The wavelength of the shear waves is longer in stiffer tissues and shorter in softer tissues. c: The wave images are then automatically processed with an ''inversion algorithm'' to create quantitative images depicting the stiffness of tissue. (For these illustrations, the portions of the wave image and elastogram corresponding to liver and spleen have been superimposed on a conventional MR image.) increasing degrees of fibrosis (17, 18) . Several MRIbased techniques have been evaluated for assessing hepatic fibrosis, including diffusion weighted imaging (DWI), perfusion MRI, MR spectroscopy (MRS), and MR elastography (MRE) (19) (20) (21) (22) . MRE is an MRI-based method for quantitatively imaging the direct consequence of liver fibrosis-increased stiffness of the hepatic parenchyma (23) (24) (25) (26) (27) (28) . The technique provides quantitative maps of tissue stiffness over large regions of the liver, whereas transient ultrasound-based techniques provide localized spot measurements at limited depth in the liver in areas where there is an acoustic window. MRE is much less operator dependent than ultrasound-based techniques. The MRE sequence can require less than a minute of acquisition time. Therefore, MRE can be readily included in standard abdominal MRI protocols which can provide a comprehensive evaluation of the liver, including assessment of fat content, presence of focal disease, and of complications of chronic liver disease such as varices. MRE is has a low rate of technical failure compared with transient ultrasound elastography. The most frequent reason for technical failure in MRE is hepatic iron overload, which can decrease hepatic signal intensity in gradient echo based MRE sequences to unacceptably low levels. Despite this limitation, MRE is the only noninvasive technique that has been able to stage liver fibrosis or diagnose mild fibrosis with reasonable accuracy as reported by a recent systemic review of imaging techniques for diagnosis and staging of hepatic fibrosis (29) . Studies have shown that MRE is highly reproducible in both volunteers and in patients with liver fibrosis (30) (31) (32) .
MRE, therefore, is a promising tool for detecting and staging liver fibrosis and for longitudinal assessment of response to antiviral or antifibrotic therapy.
Basic Principles of MRE
MRE uses propagating mechanical shear waves (range, 20-200 Hz) to probe the mechanical properties of tissues (21) . Such waves propagate more rapidly in stiffer tissue and more slowly in softer tissue. If the waves are applied continuously, the speed of propagation is reflected in the wavelength. Hence, as tissue stiffness increases, the wavelength becomes longer. Low frequency mechanical shear waves are generated with a special acoustic driver system and propagated into the body. A modified phase-contrast pulse sequence with cyclic motion encoding gradients synchronized to the mechanical waves is used to image the micron-level displacements associated with wave propagation. The imaging process can be accomplished in one or more breathholds and yields images depicting the pattern of propagating waves in the liver. The wave images are then processed with specialized software (called an inversion algorithm) to generate quantitative cross-sectional images depicting the stiffness of tissue. The tissues with shear waves of longer wavelengths are represented as areas of higher stiffness as compared to those with shorter wavelengths. Hence, MRE is a three step technique: (i) generating mechanical waves in tissue; (ii) imaging the waves with a special MRI sequence, and (iii) processing the wave information to generate elastograms, which are images that quantitatively depict tissue stiffness (Fig. 1 ).
Performing MR Elastography of Liver
The technique can be readily implemented on a conventional MR system with added hardware to generate mechanical waves, and special software for acquisition and processing. In commercially available implementations of MRE, the hardware typically consists of an active acoustic driver, located outside the magnet, which is coupled by mean of plastic tubing to a discshaped nonmetallic passive driver that is placed against the right anterior chest wall overlying the liver (Fig. 2 ) and held in place with an elastic strap around the body (Fig. 3) . For evaluating the liver, a continuous acoustic vibration at typically 60Hz is transmitted into the abdomen by means of the passive driver. The applied vibrations are well tolerated and do not cause any discomfort.
MR Elastography Sequence
Depending on the specific application, the phase-contrast MRE sequence may be based on gradientrecalled echo (GRE), spin echo (SE), or echo planar imaging (EPI) sequences, with added cyclic motionencoding gradients (MEGs) which allow shear waves with amplitudes in the micron range to be readily imaged. The MEGs are imposed along a specific direction and the applied mechanical waves are synchronized by mean of trigger pulses provided by the pulse sequence. In the resulting wave images, phase shifts caused by the cyclic motion of the spins in the presence of these MEGs provide snapshots of the mechanical waves propagating within the tissue. By adjusting the phase relationship between the mechanical excitation and the oscillating MEGs, wave images can be obtained for various phases of the repetitive wave cycle. Wave images at four evenly spaced time points over the motion cycle are typically obtained.
The MRE sequence that is currently most commonly used for clinical hepatic applications (Fig. 4) Early detection of fibrosis with MRE. Two patients with chronic hepatitis B. The patient in the upper row has normal liver stiffness, whereas the patient in the lower row has modestly elevated liver stiffness. Biopsies excluded fibrosis in the first patient and showed mild fibrosis in the second. All conventional MR images were normal in both patients. Figure 10 . Heterogeneity of fibrosis demonstrated with MRE. a: Patient with chronic hepatitis B with METAVIR stage F2 fibrosis has slightly heterogeneous, elevated liver stiffness, averaging 3.6 kPa. b: A patient with primary sclerosing cholangitis has substantial heterogeneity with increased stiffness peripherally and a mean value of 4.2 kPa. Preliminary experience suggests that this pattern is more common in patients with primary sclerosing cholangitis. c: A patient with cirrhosis due to hepatitis C has marked heterogeneity and a mean hepatic stiffness value of 7.3 kPa. 
Generating Elastograms
After the acquisition is complete, the wave images are automatically processed by the scanner to generate images that depict tissue stiffness-called elastograms. Several different types of inversion algorithms have been used, including spatial frequency estimation, and analytic solutions to the wave equation (34, 35) . These quantitatative images typically depict shear stiffness in units of kilopascals (kPa), and may be displayed in a gray scale or with a color scale (36) (Fig. 5) .
Analysis of Elastograms
Liver stiffness is typically assessed by drawing regions of interest (ROI's) in the elastograms. ROIs should be placed only in regions of the liver that have adequate wave amplitude and should not extend closer than approximately one-half wavelength to the liver margin to avoid edge effects. Large vessels, the gall bladder fossa, and any areas affected by cardiac and vascular artifacts should also be excluded. ROIs can be either geographic or oval in shape (Fig. 6 ).
Clinical Applications of Hepatic MRE

Detection of Liver Fibrosis
Normal liver parenchyma has shear stiffness values less than 3 kPa (23,25,27,28,37-39 ). Hepatic fibrosis can be diagnosed with high sensitivity and specificity if the hepatic stiffness is above this value. MRE has also been shown to be useful for differentiating between various stages of fibrosis (25, 37, 38) . Liver stiffness increases incrementally with histological stage of fibrosis (Figs. 7, 8) .
Studies have also shown that MRE can be used to detect liver fibrosis well before other imaging signs of fibrosis are seen (Fig. 9) . MR Elastography is useful for differentiating patients with clinically important hepatic fibrosis (METAVIR stage F2-4) from those individuals with lesser degrees of fibrosis, including persons without chronic liver disease (25) (26) (27) (37) (38) (39) . Most of the studies reporting the accuracy of MRE have included patients with fibrosis from varied etiologies. It is thought that the degree, extent, pattern, and distribution of fibrosis may be different in chronic liver diseases with various etiologies. These differences may affect the cut off value to be used for distinguishing the stages of fibrosis in different chronic liver diseases. Furthermore, fibrosis staging with histopathology is defined by architectural changes and not the total amount of fibrosis. Whether MRE is affected by the amount of fibrosis or the pattern of architectural changes is not known and is a potential area of research in future. Therefore, more studies with larger patient populations, preferably of same etiology are needed to confirm the sensitivity and specificity of MRE and to standardize the technique. Accurate cutoff values incorporating sensitivity and specificity Figure 15 . Intravenous gadolinium contrast administration does not affect hepatic stiffness. MRE in a chronic hepatitis B patient with biopsy confirmed stage 3 fibrosis before (top row) and after (bottom row) administration of intravenous gadolinium agent shows no significant change in hepatic stiffness (3.6 and 3.7 kPa respectively). values need to be determined for different etiologies. Most studies to date have found that a cutoff value of 3 kPa is useful to distinguish patients with normal liver parenchyma from those with steatohepatitis or fibrosis.
While the presence of liver fibrosis appears to be consistently associated with increased hepatic parenchymal stiffness, the reverse is not always true. Studies with transient elastography have shown that acute inflammation of liver without presence of fibrosis can cause increased hepatic stiffness (40) . Similar observations are emerging with MRE and, in particular, marked elevation of MRE-assessed hepatic stiffness without biopsy evidence of fibrosis has been reported in patients with acute hepatitis (41) .
Hepatic fibrosis may not be a homogenous process, creating the potential for sampling error in biopsybased diagnosis (42) . MRE provides a unique opportunity to visualize the spatial pattern of fibrosis in the liver and preliminary observations have indicated that heterogeneity is often apparent especially in the early stages (Fig. 10) . MRE provides an opportunity for biopsy guidance (43) .
Hepatic MRE is usually performed in a fasting state, because increased postprandial portal blood flow may cause a dynamic increase in liver stiffness in patients with liver disease, potentially leading to an overestimation of the extent of fibrosis (44, 45) . Hepatic MRE can be performed either before or after intravenous gadolinium administration, as liver stiffness values are not significantly affected by intravenous gadolinium (46) (Fig. 11) .
Studies comparing the MRE with Fibroscan are few (27, 47) . In one study, MRE had a higher technical success rate than Fibroscan and a better diagnostic accuracy (0.994 for F > 2; 0.985 for F > 3; 0.998 for F > 4) than Fibroscan and aspartate aminotransferase to platelets ratio index (APRI), and the combination of Fibroscan and APRI (0.837, 0.709, and 0.849 for F > 2; 0.906, 0.816, and 0.936 for F > 3; 0.930, 0.820, and 0.944 for F > 4, respectively) (27) . 
MRE Can be Performed in Most Patients
MRE technique is well tolerated by most patients and can be incorporated into a standard liver MRI study with minimal effect on exam time. MRE is not affected by obesity (Fig. 12), ascites (Fig. 13) or bowel interposition between liver and anterior abdominal wall (Fig. 14) , all of which may limit the application of ultrasound-based quantitative elastography.
Fatty Change in the Liver Does Not Affect Measurement of Liver Stiffness
In patients with nonalcoholic fatty liver disease (NAFLD), steatosis alone does not appear to have a significant effect on hepatic stiffness (Fig. 15) (25) . However, it has been shown that if the disease progresses to inflammation (nonalcoholic steatohepatitis or NASH), MRE-assessed hepatic stiffness does increase, even before the onset of fibrosis (48) . More studies on utility of MRE in this particular and important cause of chronic liver disease are needed.
MRE May be Useful in Characterization of Liver Tumors
Preliminary studies have shown that benign hepatic tumors tend to show lower or similar stiffness to that of normal liver whereas malignant lesions tend to have higher stiffness than normal liver and benign tumors (Fig. 16) . A study of 44 hepatic masses in 29 patients showed that all of the observed malignant tumors had stiffness values above 5 kPa, whereas all of the benign hepatic tumors and normal liver parenchymal measurements were below this value (49) . The results indicate that MRE shows promise as a method for characterizing focal hepatic lesions.
Limitations of MRE
MRE is typically a breathhold technique and therefore requires co-operation by patients similar to other MRI-based hepatic sequences (Fig. 17) . In patients with moderate to severe iron overload due to hemochromatosis or hemosiderosis, the hepatic MRI signal may be so low that waves cannot be adequately visualized with a gradient-echo based MRE sequence. (Fig. 17) (50) . This limitation may be overcome by implementing alternative pulse sequences with shorter echo times such as spin-echo EPI based MRE (Fig. 18) (51) .
DISCUSSION
With growing clinical experience, MRE is emerging as a noninvasive alternative to biopsy in patients with suspected hepatic fibrosis. The technique may be especially relevant for surveillance of patients receiving therapeutic agents with known hepatotoxic effects and to assess the longitudinal response to antifibrotic treatment ( Fig. 19) (52) .
Given the high test-retest repeatability of MRE, the technique may be especially suitable as an alternative to biopsy for clinical trials of antifibrotic drugs (31).
There is scope for further refinement of the technique especially to optimize the image quality. Currently applied MRE technique has lower resolution than the standard MRI sequences. True three-dimensional imaging with increasingly sophisticated inversion algorithms can help improve the resolution and accuracy. This may be particularly useful for detection of focal lesions. Reducing acquisition time with reduced k-space acquisition and use of parallel imaging may help minimize breath hold artifacts. Other areas for improvement of image quality are to improve signal to noise ratio in patients with iron overload with using spin echo, fast spin echo and echo planar imaging methods.
Many research opportunities seem apparent. By applying more elaborate mechanical models to the processing of wave data, it is possible to estimate new independent tissue characterization parameters that account for properties such as attenuation, anisotropy, and nonlinearity. By using these additional parameters, it may be possible to augment the specificity of MRE to discriminate between the effects of inflammation, edema, passive congestion, fibrosis, and scarring.
In summary, emerging evidence indicates that MRE is a reliable noninvasive technique for evaluating hepatic fibrosis. It is safer, less expensive, and potentially less affected by sampling errors than biopsy. MRE of the liver can be performed in most patients with liver disease including those with ascites or obesity.
